Abstract
Background Studies have focused on enhancing flap viability using superoxide dismutase (SOD), but only a few used SOD from human origin, and most gave the compound systemically. We evaluated the ability of SOD to improve random skin flap survival using human recombinant copper-zinc superoxide dismutase (Hr-CuZnSOD) in variable doses, injected intradermally into the flap. Methods Seventy male Sprague Dawley rats were randomly assigned into 4 groups. Cephalic random pattern flaps were elevated on their backs and intradermal injections of different dosages of Hr-CuZnSOD were given 15 minutes before surgery. Flap survival was evaluated by fluorescein fluorescence. Analysis of variance (ANOVA) and t test statistical analyses were performed. Results Flap survival in all treated groups was significantly better than in the controls. Conclusions The beneficial effect of HR-CuZnSOD on flap survival is attained when it is given intradermally into the flap tissue. Theoretically, Hr-CuZnSOD delivered with local anesthetics used in flap elevation may be a valuable clinical tool.
Original language | English |
---|---|
Pages (from-to) | 1265-1268 |
Number of pages | 4 |
Journal | Head and Neck |
Volume | 35 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2013 |
Keywords
- SOD
- flaps
- oxygen free radicals
- rats
- survival